Bristol Myers Squibb Network of Women (B-NOW San Diego) and #HBASanDiego are excited to have Tiffany Sepp as one of exceptional panelists in an in-person, moderated panel discussion on November 9th, 2023. We will hear her and other panelists' insights on career growth, overcoming challenges, and achieving success in work and life. This event will feature time for networking with light refreshments and drinks, and an audience Q & A with the panelists. Register: https://bit.ly/HBASD110923 #HBAimpact
Vanguard Clinical, Inc.
生物技术研究
San Diego，CA 2,315 位关注者
Contract Research Organization and Functional Service Provider offering "white glove service", transparency, & passion
关于我们
Healthcare is about people. That’s why at Vanguard Clinical we work to build the best possible relationships with our clients and the medical professionals we engage on their behalf. Motivated investigators achieve faster enrollment with fewer screen failures and protocol deviations, saving our clients both time and money. We look forward to building a long lasting relationship with your organization. With over 20 years of industry experience, Vanguard Clinical Inc. is a leader in clinical trial management. Our highly talented and diverse team of consultants has the expertise to carry out all phases of trials in many therapeutic areas. At Vanguard Clinical, we understand that the right patient population can be anywhere. With experience conducting trials on five continents, we recognize the challenges and logistics unique to certain areas of the world. From regulations to training, Vanguard Clinical employs the optimal strategy to ensure trials are conducted consistently and return the best possible data. A successful clinical trial can be a marathon, and Vanguard Clinical will be by your side the entire way. During startup, we can manage or assist with initial feasibility and budget forecasting, negotiating contracts with vendors and clinical sites, protocol writing, and Investigator on-boarding. As trials progress, we provide expert analysis to ensure resources are being utilized efficiently. We pride ourselves on quality results, integrity of data, and ongoing process development to ensure the success of the projects for our clients. We strive to be innovators and are always refining our processes to provide a tight feedback loop between the monitors in the field and our clients, keeping them continuously informed about the status of a trial.
- 网站
-
https://vanguardclinical.com
Vanguard Clinical, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- San Diego，CA
- 类型
- 私人持股
- 创立
- 2012
- 领域
- Clinical Operations、Clinical Trial Management、Clinical Monitoring、Trial Master File Management、Clinical Development、Vendor Oversight、CRO Oversight和Functional Service Provider
地点
-
主要
获取路线
12265 El Camino Real
Suite 200
US，CA，San Diego，92130
Vanguard Clinical, Inc.员工
动态
-
President & CEO of Vanguard Clinical, Inc., a boldly distinct CRO in Rare Disease, Oncology, and CNS
Incredibly disappointing news to see this important meeting is being “postponed”! But this only fortifies my drive and passion for the important work we are doing in rare disease research. I hope to still meet with many colleagues in the area next week! I will not give up! 💪 https://lnkd.in/gmURZCqa
-
Vanguard Clinical's CEO, Tiffany Sepp, and Business Development Partner, John Hixon, are looking forward to connecting with you at Nevada Psychiatric Association 30th Annual National Psychopharmacology Update™!
-
-
Don't miss a chance to connect with our CEO Tiffany Sepp and our Business Development Partner John Hixon at SCOPE in February!
-
-
An inspection ready Trial Master File (TMF) starts with a strong team – and we are proud to introduce ours here at Vanguard Clinical! Our dedicated TMF experts are ready to provide exceptional support and partner with you on your next study. Reach out today and #ExperienceTheVanguardVibe
-
-
For the past few years, we have been honored to support Phase 3 studies in Major Depressive Disorder, gaining invaluable experience and becoming subject matter experts in this critical therapeutic area. Our journey has been shaped by collaboration, innovation, and the meaningful relationships we have built along the way. Today, we are proud to showcase our exceptional team of CRAs, Clinical Operations professionals, and TMF managers who are ready to support your next CNS study. If you’re looking for a team that combines expertise, passion, and dedication, look no further! Let’s connect to explore how we can support your CNS study needs! #ExperienceTheVanguardVibe
-
-
President & CEO of Vanguard Clinical, Inc., a boldly distinct CRO in Rare Disease, Oncology, and CNS
We're hiring for a new sales/business development lead! If you know someone in your network with CRO or pharma services sales experience, please pass along this opportunity. Join us in shaping the future of our business in 2025! Explore further and apply here:
Senior Business Development Leader
vanguardclinical.bamboohr.com
-
ForeBatten just returned from The 2024 NCL Translational meeting in Chicago. This meeting is organized by Our Promise to Nicholas Foundation with help from Weimer Lab. We (Karen and David) first attended this meeting in 2017, just 6 months after Amelia & Makenzie’s diagnosis. It was not inclusive of CLN3 at the time, but we were told ‘go there, (by Jill Weimer, PhD) all the scientists you need to talk to are all in the same room.' So David and I went. I became enthralled with the science and David spent the entire time drawing golf courses. That meeting was the catalyst for ForeBatten building an incredible team of scientists dedicated to this horrible disease. So THANK YOU Heather and Chris, this conference makes a difference! Seven years later, we found ourselves standing before the same group of researchers introducing the ForeBatten team. It was our first opportunity to present on the science, clinical protocol and roadmap of how we successfully brought Zebronkysen to Amelia and Makenzie in an accelerated timeframe. This time, David joined remotely and ended the meeting with a truly inspiring reflection. It was a pinch-me experience. We are so proud and grateful for the amazing individuals who passionately embraced our family and made the treatment dream a reality. This is just the beginning for ForeBatten Foundation. Tiffany Sepp Russell Gotschall Carol Mabry Schwimmer Michelle Hastings Yael Shiloh Malawsky Karen Kahn David Kahn
-
-
-
-
-
+9
-
-
President & CEO of Vanguard Clinical, Inc., a boldly distinct CRO in Rare Disease, Oncology, and CNS
This week, I am thrilled to share my and Vanguard Clinical, Inc.’s collaboration with the ForeBatten Foundation on the development of #Zebronkysen at the 8th annual Translational Research Conference for the Management of NCLs in Chicago! #ForeBattenFoundation #ResearchConference #Chicago #NCLs #BattenDisease
-